| Filed On | Filing |
|---|---|
| 08 Dec 2021 |
Form 4: Koby Michael, Director
Returned 1,744,017 shares to the issuer |
| 08 Dec 2021 |
Form 4: Vizirgianakis Stavros G., Director
Returned 2,136,478 shares to the issuer |
| 08 Dec 2021 |
Form 4: Patton Thomas M, Director
Returned 104,500 shares to the issuer |
| 08 Dec 2021 |
Form 4: Ludecker Robert S, SVP, Global Sales - Marketing
Returned 319,443 shares to the issuer |
| 08 Dec 2021 |
Form 4: Laviolette Paul A, Director
Returned 1,744,017 shares to the issuer |
| 08 Dec 2021 |
Form 4: Dwyer Joseph P, Chief Financial Officer
Returned 276,200 shares to the issuer |
| 08 Dec 2021 |
Form 4: Beyer Pat, Director
Returned 20,000 shares to the issuer |
| 02 Jul 2021 |
Form 4: Waggoner Jonathan Jay, SVP, Wound Sales
Granted 15,000 Stock Option |
| 02 Jul 2021 |
Form 4: Patton Thomas M, Director
Granted 15,000 Stock Option |
| 02 Jul 2021 |
Form 4: Vizirgianakis Stavros G., Director
Granted 150,000 Stock Option |
| 02 Jul 2021 |
Form 4: Koby Michael, Director
Granted 15,000 Stock Option |
| 02 Jul 2021 |
Form 4: Klugewicz Sharon W, Director
Granted 15,000 Stock Option |
| 02 Jul 2021 |
Form 4: Laviolette Paul A, Director
Granted 15,000 Stock Option |
| 02 Jul 2021 |
Form 4: Ludecker Robert S, SVP Sales - Surgical
Granted 20,000 Stock Option |
| 02 Jul 2021 |
Form 4: Dwyer Joseph P, Chief Financial Officer
Granted 50,000 Stock Option |
| 18 May 2021 |
Form 4: Beyer Pat, Director
Granted 20,000 Stock Option |
| 05 Feb 2021 |
Form 4: 1315 Capital Management, Llc, 10% owner and 1 other
Disposed of 1,952 shares (Other Transaction) ($38.1K) |
| 03 Dec 2020 |
Form 4: Waggoner Jonathan Jay, SVP, Wound Sales
Granted 30,000 Stock Option |
| 02 Jul 2020 |
Form 4: Vizirgianakis Stavros G., Director
Granted 50,995 Stock Option |
| 02 Jul 2020 |
Form 4: Laviolette Paul A, Director
Granted 3,060 Stock Option |
Loading...